Unity Biotechnology Q3 EPS $(0.51), Inline

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.45) per share from the same period last year.

Benzinga · 11/06/2019 21:56

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.45) per share from the same period last year.